Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 4/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | TERT | O14746 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 2/20 | 0.58 |
| ▸ | CA1 | P00915 | 2/20 | 0.58 |
| ▸ | CA2 | P00918 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | CA7 | P43166 | 2/20 | 0.58 |
| ▸ | CA9 | Q16790 | 2/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | CA4 | P22748 | 1/20 | 0.58 |
| ▸ | CA6 | P23280 | 1/20 | 0.58 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | XDH | P47989 | 2/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.52 |
| ▸ | DBH | P09172 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29950592 | 1.00 | SNCA (0.60) | SNCAMAPTTERTKDM4ECA12 | |
| SCHEMBL28137509 | 0.81 | ALDH1A1 (0.43) | SNCAMAPTTERTCA12CA1 | |
| SCHEMBL19650956 | 0.81 | DPP4 (0.47) | SNCAMAPTTERTKDM4EGAA | |
| SCHEMBL2221664 | 0.80 | ALDH5A1 (0.59) | SNCAMAPTTERTKDM4ECA12 | |
| Hydrochloric Acid SCHEMBL15861834 | 0.78 | ALDH5A1 (0.57) | SNCAMAPTTERTKDM4ECA12 | |
| SCHEMBL31753888 | 0.78 | CHUK (0.45) | SNCAMAPTTERTKDM4EPTGS2 | |
| SCHEMBL222221 | 0.77 | ALDH1A1 (0.74) | MAPTRECQL | |
| SCHEMBL14416842 | 0.77 | SNCA (0.65) | SNCAMAPTTERTKDM4ECA12 | |
| SCHEMBL28272168 | 0.77 | SNCA (0.55) | SNCAMAPTTERTKDM4ECA12 | |
| SCHEMBL28245506 | 0.77 | TUBB1 (0.57) | SNCARECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10865180-B2 | Process for the preparation of l-Norepinephrine bitartrate monohydrate having high enantiomeric purity | HARMAN FINOCHEM LIMITED (IN) | 2020-12-15 | — | — | US | disclosed |
| US-20200048185-A1 | PROCESS FOR THE PREPARATION OF l-NOREPINEPHRINE BITARTRATE MONOHYDRATE HAVING HIGH ENANTIOMERIC PURITY | HARMAN FINOCHEM LIMITED | 2020-02-13 | — | — | US | disclosed |
| WO-2013008247-A1 | PROCESS FOR PREPARATION OF (DL) -NOREPINEPHRINE ACID ADDITION SALT, A KEY INTERMEDIATE OF (R) - (-) - NOREPINEPHRINE | NEON LABORATORIES LTD. (IN) | 2013-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10865180-B2 | Process for the preparation of l-Norepinephrine bitartrate monohydrate having high enantiomeric purity | SLC6A2, SLC6A3, SLC6A6 | SNCA 179/4885MAPT 266/4885TERT 3710/4885 |
| US-20200048185-A1 | PROCESS FOR THE PREPARATION OF l-NOREPINEPHRINE BITARTRATE MONOHYDRATE HAVING HIGH ENANTIOMERIC PURITY | SLC6A2, SLC6A3, SLC6A6 | SNCA 179/4885MAPT 266/4885TERT 3710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.